IMPC Gene variants with abnormal lipid homeostasis
Total number of significant genotype-phenotype associations: 1359
Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Parameter | Phenotyping Center |
P Value |
---|---|---|---|---|---|---|---|
Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Apoc4 Apoc4tm1.1(KOMP)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
0.00 | |
Apoe Apoetm1Unc |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
0.00 | |
Apoe Apoetm1Unc |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
WTSI MGP |
0.00 | |
Atp11c Atp11cem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
0.00 | |
Atp13a3 Atp13a3em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
0.00 | |
Bscl2 Bscl2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
0.00 | |
Duoxa2 Duoxa2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Duoxa2 Duoxa2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Duoxa2 Duoxa2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
0.00 | |
Ldlr Ldlrtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
0.00 | |
Lepr Leprtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
0.00 | |
Tpo Tpoem1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
0.00 | |
Tmem237 Tmem237tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
7.01×10-45 | |
Slc29a3 Slc29a3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.22×10-43 | |
Slc29a3 Slc29a3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.26×10-41 | |
Gimap6 Gimap6tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.39×10-39 | |
Abcg8 Abcg8tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
2.90×10-37 | |
Atp13a3 Atp13a3em1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.49×10-33 | |
Gimap6 Gimap6tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.28×10-28 | |
Dll1 Dll1tm1Gos |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical chemistry (GMC) |
HMGU EuroPhenome |
3.58×10-27 | |
Abcg8 Abcg8tm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
1.58×10-25 | |
Pcsk9 Pcsk9tm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.86×10-25 | |
Apoc4 Apoc4tm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
8.78×10-24 | |
Tnip1 Tnip1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.30×10-23 | |
Nr1h4 Nr1h4Nr1h4 |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS EuroPhenome |
1.87×10-22 | |
Atp8b1 Atp8b1em1(IMPC)Tcp |
HOM | Late adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
9.00×10-22 | |
Akt2 Akt2tm1Wcs |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
WTSI MGP |
1.05×10-21 | |
Apoe Apoetm1Unc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
WTSI MGP |
2.29×10-21 | |
Duox2 Duox2em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.37×10-21 | |
Pcsk9 Pcsk9tm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
3.71×10-21 | |
Txnip Txniptm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.03×10-20 | |
Kctd1 Kctd1em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.67×10-20 | |
Tnip1 Tnip1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.92×10-20 | |
Ldlr Ldlrtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.24×10-19 | |
Dennd5b Dennd5bem1(IMPC)Tcp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
1.38×10-19 | |
Kctd1 Kctd1em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.76×10-18 | |
Clcn1 Clcn1em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
4.19×10-18 | |
Cav1 Cav1em2(IMPC)Ics |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.13×10-17 | |
Fbrs Fbrsem1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
3.68×10-17 | |
Scarb1 Scarb1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
BCM IMPC |
5.44×10-17 | |
Angptl3 Angptl3tm2b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
8.45×10-17 | |
Dennd5b Dennd5bem1(IMPC)Tcp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.35×10-16 | |
Tmem212 Tmem212em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
6.00×10-16 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.57×10-15 | |
Rnf10 Rnf10tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
1.65×10-15 | |
Abcg8 Abcg8tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
2.64×10-15 | |
Atp13a3 Atp13a3em1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.26×10-15 | |
Tchp Tchptm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.61×10-15 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
6.44×10-15 | |
Slc29a3 Slc29a3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.45×10-14 | |
Bbs5 Bbs5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
3.52×10-14 | |
Sec16b Sec16btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.04×10-14 | |
Rxrg RxrgRxrg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
4.63×10-14 | |
Rxrg RxrgRxrg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
9.28×10-14 | |
Trh Trhem1(IMPC)Tcp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.86×10-13 | |
Sec16b Sec16btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
2.62×10-13 | |
Sox21 Sox21em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
2.87×10-13 | |
Nr1h4 Nr1h4Nr1h4 |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
ICS EuroPhenome |
3.07×10-13 | |
Usp47 Usp47tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MARC IMPC |
3.82×10-13 | |
Tex261 Tex261tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.04×10-13 | |
Bscl2 Bscl2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
5.49×10-13 | |
Hnf4a Hnf4atm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
6.79×10-13 | |
Fbxo10 Fbxo10tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
6.87×10-13 | |
Adipor1 Adipor1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.56×10-13 | |
Atp11c Atp11cem1(IMPC)J |
HEM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.58×10-13 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.60×10-12 | |
Cav1 Cav1em2(IMPC)Ics |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
1.70×10-12 | |
Usp47 Usp47tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
2.11×10-12 | |
Ptpn23 Ptpn23tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
2.39×10-12 | |
Akap9 Akap9tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
2.52×10-12 | |
Ttc28 Ttc28tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
2.69×10-12 | |
Angptl3 Angptl3tm2b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
3.44×10-12 | |
Nr1h4 Nr1h4Nr1h4 |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
5.25×10-12 | |
D6Wsu163e D6Wsu163etm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.36×10-12 | |
Arhgef4 Arhgef4tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.39×10-12 | |
Serf1 Serf1tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
5.60×10-12 | |
Cyp19a1 Cyp19a1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.70×10-12 | |
Nrxn1 Nrxn1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.57×10-12 | |
Brd7 Brd7tm3a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
WTSI MGP |
6.98×10-12 | |
Hnf4a Hnf4atm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
7.53×10-12 | |
Zfand6 Zfand6em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
8.70×10-12 | |
Sik3 Sik3tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
9.34×10-12 | |
Acsl5 Acsl5tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.02×10-11 | |
Angptl3 Angptl3tm2b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.13×10-11 | |
Ppp5c Ppp5ctm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.15×10-11 | |
Nisch Nischtm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.21×10-11 | |
Serf1 Serf1tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.67×10-11 | |
Cox8a Cox8aem1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
1.69×10-11 | |
Akap9 Akap9tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
1.86×10-11 | |
Atp11c Atp11cem1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.91×10-11 | |
Peak1 Peak1em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.18×10-11 | |
Gm5127 Gm5127em1(IMPC)J |
HEM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.37×10-11 | |
Plcg2 Plcg2Ali14 |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU EuroPhenome |
2.82×10-11 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HEM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.53×10-11 | |
Tex261 Tex261tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.45×10-11 | |
Vangl2 Vangl2Lp |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
5.94×10-11 | |
Tchp Tchptm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.35×10-11 | |
Gnb2 Gnb2em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
8.84×10-11 | |
Ano6 Ano6em3(IMPC)Tcp |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
8.97×10-11 | |
Far2 Far2tm2b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
9.38×10-11 | |
Dym Dymem1(IMPC)Tcp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
9.46×10-11 | |
Rexo2 Rexo2tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.76×10-11 | |
Polr3d Polr3dem1(IMPC)Tcp |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
9.90×10-11 | |
Hr Hrem1(IMPC)H |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.19×10-10 | |
Reg3g Reg3gtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.29×10-10 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.31×10-10 | |
Folr1 Folr1tm1.1(KOMP)Vlcg |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
1.36×10-10 | |
Akap9 Akap9tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.44×10-10 | |
Larp1 Larp1em1(IMPC)Mbp |
HET | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.56×10-10 | |
Sik3 Sik3tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.90×10-10 | |
Atp11c Atp11cem1(IMPC)J |
HEM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.06×10-10 | |
Tchp Tchptm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.16×10-10 | |
Abcd3 Abcd3em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.34×10-10 | |
Tnfaip1 Tnfaip1tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
2.45×10-10 | |
Elovl5 Elovl5em1(IMPC)Tcp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
2.69×10-10 | |
Gna11 Gna11tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
3.34×10-10 | |
Reg3g Reg3gtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.35×10-10 | |
Sec24a Sec24atm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.62×10-10 | |
Ct45a Ct45atm1e(KOMP)Wtsi |
HEM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.79×10-10 | |
Peak1 Peak1em1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.86×10-10 | |
Reg3g Reg3gtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.90×10-10 | |
Dym Dymem1(IMPC)Tcp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
4.52×10-10 | |
Acsl5 Acsl5tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.72×10-10 | |
Eftud2 Eftud2tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
5.36×10-10 | |
Dcun1d3 Dcun1d3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.78×10-10 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
7.46×10-10 | |
Lypd3 Lypd3tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
7.95×10-10 | |
Nrxn2 Nrxn2em1(IMPC)H |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.21×10-10 | |
Ap4e1 Ap4e1em2(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
8.31×10-10 | |
Gnao1 Gnao1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
9.40×10-10 | |
Abcd3 Abcd3em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.00×10-09 | |
Adipor1 Adipor1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.02×10-09 | |
Sec24a Sec24atm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.08×10-09 | |
Zfp638 Zfp638em1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.16×10-09 | |
Apoc4 Apoc4tm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.17×10-09 | |
Cisd2 Cisd2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
1.41×10-09 | |
Lgals7 Lgals7tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.49×10-09 | |
Tmem132b Tmem132bem1(IMPC)Ccpcz |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
1.52×10-09 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.54×10-09 | |
Col18a1 Col18a1tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
1.58×10-09 | |
Cyp7a1 Cyp7a1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.70×10-09 | |
Nrxn1 Nrxn1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.83×10-09 | |
Ccdc18 Ccdc18tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.85×10-09 | |
Ct45a Ct45atm1e(KOMP)Wtsi |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.91×10-09 | |
Baz1b Baz1btm2a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
2.03×10-09 | |
Baat Baatem1(IMPC)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.11×10-09 | |
Dcun1d3 Dcun1d3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.15×10-09 | |
Cxcl9 Cxcl9tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.17×10-09 | |
Cenpo Cenpotm1b(KOMP)Mbp |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
2.31×10-09 | |
Ercc8 Ercc8em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.65×10-09 | |
Ak4 Ak4em1(IMPC)Kmpc |
HOM | Late adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
KMPC IMPC |
2.74×10-09 | |
Snx6 Snx6em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.85×10-09 | |
Dbn1 Dbn1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
BCM IMPC |
3.53×10-09 | |
Pcsk2 Pcsk2em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.16×10-09 | |
Tmem203 Tmem203em1(IMPC)H |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.67×10-09 | |
Peak1 Peak1em1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.82×10-09 | |
Lepr Leprtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.95×10-09 | |
Prkab1 Prkab1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
5.18×10-09 | |
Setmar Setmartm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.62×10-09 | |
Larp1 Larp1em1(IMPC)Mbp |
HET | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
5.63×10-09 | |
Mindy1 Mindy1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI EuroPhenome |
6.04×10-09 | |
Hells Hellstm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
6.13×10-09 | |
Nisch Nischtm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.42×10-09 | |
Hdac1 Hdac1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
6.52×10-09 | |
Dusp7 Dusp7tm1(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MARC IMPC |
7.14×10-09 | |
Cfap119 Cfap119tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
7.81×10-09 | |
Sox21 Sox21em1(IMPC)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
7.88×10-09 | |
Setmar Setmartm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI EuroPhenome |
7.99×10-09 | |
Dntt Dntttm2b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.09×10-09 | |
Tial1 Tial1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
8.44×10-09 | |
Crispld2 Crispld2tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
8.52×10-09 | |
Elovl5 Elovl5em1(IMPC)Tcp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
8.68×10-09 | |
Cyp4b1 Cyp4b1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
9.51×10-09 | |
Usp33 Usp33tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
9.66×10-09 | |
Trh Trhem1(IMPC)Tcp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
9.79×10-09 | |
Atad2b Atad2btm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.05×10-08 | |
Ccdc120 Ccdc120tm1.1(KOMP)Vlcg |
HEM | Early adult | increased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
1.08×10-08 | |
Baat Baatem1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.12×10-08 | |
Clcnkb Clcnkbem1(IMPC)Mbp |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.19×10-08 | |
Nhlh2 Nhlh2tm1b(KOMP)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
1.21×10-08 | |
Zc3h13 Zc3h13em1(IMPC)J |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.22×10-08 | |
Med23 Med23em1(IMPC)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.22×10-08 | |
Pak1 Pak1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.26×10-08 | |
Nrxn2 Nrxn2em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.29×10-08 | |
Dll1 Dll1tm1Gos |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical chemistry (GMC) |
HMGU EuroPhenome |
1.38×10-08 | |
Aire Airetm1.1(NCOM)Mfgc |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
1.40×10-08 | |
Gm20646 Gm20646em1(IMPC)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.51×10-08 | |
Smyd2 Smyd2tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.62×10-08 | |
Slc38a10 Slc38a10tm2a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
1.77×10-08 | |
Ift43 Ift43tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
BCM IMPC |
1.81×10-08 | |
Ct45a Ct45atm1e(KOMP)Wtsi |
HEM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.82×10-08 | |
Ccdc77 Ccdc77tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.87×10-08 | |
Mysm1 Mysm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
HMGU EuroPhenome |
1.88×10-08 | |
Ttc28 Ttc28tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.92×10-08 | |
Btbd9 Btbd9tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.93×10-08 | |
Zfp175 Zfp175tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.94×10-08 | |
Kics2 Kics2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MARC IMPC |
2.10×10-08 | |
Ptpn23 Ptpn23tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
2.26×10-08 | |
Il2ra Il2ratm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
2.27×10-08 | |
Pde6b Pde6bPde6b |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical chemistry (GMC) |
HMGU EuroPhenome |
2.50×10-08 | |
Tmem167 Tmem167tm1a(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
2.51×10-08 | |
Elk4 Elk4tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell EuroPhenome |
2.56×10-08 | |
Camsap3 Camsap3tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
2.66×10-08 | |
Cfap119 Cfap119tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
2.78×10-08 | |
Ap2a2 Ap2a2em1(IMPC)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.80×10-08 | |
Btbd9 Btbd9tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
3.09×10-08 | |
Cenpo Cenpotm1b(KOMP)Mbp |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
3.15×10-08 | |
Chrna7 Chrna7tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.18×10-08 | |
Zfp84 Zfp84tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.19×10-08 | |
Setd1a Setd1atm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
3.22×10-08 | |
Ct45a Ct45atm1e(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.27×10-08 | |
Dusp3 Dusp3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.32×10-08 | |
Setd1a Setd1atm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.39×10-08 | |
Sar1b Sar1btm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.40×10-08 | |
Aifm3 Aifm3em1(IMPC)Rbrc |
HOM | Late adult | abnormal circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
RBRC IMPC |
3.74×10-08 | |
Nsf Nsftm1b(KOMP)Mbp |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
4.01×10-08 | |
Larp6 Larp6em1(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
4.08×10-08 | |
Tbc1d5 Tbc1d5em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.18×10-08 | |
Sar1b Sar1btm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.32×10-08 | |
Hr Hrem1(IMPC)H |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.34×10-08 | |
Fbxo27 Fbxo27em2(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
5.12×10-08 | |
Rc3h2 Rc3h2tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU EuroPhenome |
5.20×10-08 | |
Elmod2 Elmod2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.24×10-08 | |
Etv6 Etv6em1(IMPC)Rbrc |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
RBRC IMPC |
5.76×10-08 | |
Zfand6 Zfand6em1(IMPC)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
6.42×10-08 | |
Grin2d Grin2dtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
7.32×10-08 | |
Arhgap22 Arhgap22tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.66×10-08 | |
Prkab1 Prkab1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.75×10-08 | |
Stk32a Stk32atm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
7.80×10-08 | |
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.82×10-08 | |
Clcnkb Clcnkbem1(IMPC)Mbp |
HOM | Late adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
8.14×10-08 | |
Lactb Lactbtm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
8.37×10-08 | |
Gpr146 Gpr146em1(IMPC)H |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.73×10-08 | |
Ezh2 Ezh2tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
8.75×10-08 | |
Tial1 Tial1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
9.18×10-08 | |
Abcc2 Abcc2tm2b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.63×10-08 | |
Mysm1 Mysm1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
9.68×10-08 | |
Cd36 Cd36em1(IMPC)Mbp |
HOM | Late adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.05×10-07 | |
Serpinb5 Serpinb5tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.06×10-07 | |
Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.14×10-07 | |
Cib2 Cib2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.17×10-07 | |
Arhgef4 Arhgef4tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
1.30×10-07 | |
Camsap3 Camsap3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.30×10-07 | |
Ercc8 Ercc8em1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.30×10-07 | |
Slain2 Slain2em1(IMPC)J |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.42×10-07 | |
Lgals7 Lgals7tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.44×10-07 | |
Slc3a1 Slc3a1tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.45×10-07 | |
Nfkb1 Nfkb1tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.45×10-07 | |
Fads1 Fads1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.52×10-07 | |
U2af2 U2af2em1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.52×10-07 | |
Trim8 Trim8em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.52×10-07 | |
Trip13 Trip13tm1.1(KOMP)Vlcg |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.55×10-07 | |
Fam234b Fam234btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.55×10-07 | |
Dntt Dntttm2b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.58×10-07 | |
Zranb3 Zranb3em1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.63×10-07 | |
Zc3h13 Zc3h13em1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.65×10-07 | |
Mta1 Mta1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.74×10-07 | |
Epx Epxtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
1.76×10-07 | |
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
1.77×10-07 | |
Duox2 Duox2em1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.78×10-07 | |
Hspb6 Hspb6em1(IMPC)J |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.78×10-07 | |
Mdk Mdktm1.1(KOMP)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.84×10-07 | |
Dym Dymem1(IMPC)Tcp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
1.85×10-07 | |
Pex3 Pex3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.97×10-07 | |
Slc46a3 Slc46a3tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.11×10-07 | |
Elmod2 Elmod2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.12×10-07 | |
Diaph3 Diaph3tm1b(KOMP)Mbp |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
2.14×10-07 | |
Ywhab Ywhabtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
2.16×10-07 | |
Far2 Far2tm2b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
2.16×10-07 | |
Vsig4 Vsig4tm1b(EUCOMM)Hmgu |
HEM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.17×10-07 | |
Dsg1c Dsg1cem1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.21×10-07 | |
E130308A19Rik E130308A19Rikem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.24×10-07 | |
Ipo7 Ipo7em1(IMPC)Mbp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
2.26×10-07 | |
Usp33 Usp33tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
2.36×10-07 | |
Hdac3 Hdac3tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
2.37×10-07 | |
Col11a2 Col11a2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
2.37×10-07 | |
Trim13 Trim13em1(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
2.44×10-07 | |
Unc5cl Unc5clem1(IMPC)Mbp |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.50×10-07 | |
Entr1 Entr1em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.58×10-07 | |
Elmod1 Elmod1tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.63×10-07 | |
Nab2 Nab2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
2.64×10-07 | |
Bhlhe40 Bhlhe40tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.81×10-07 | |
Slc3a1 Slc3a1tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.85×10-07 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.86×10-07 | |
Cdkn1b Cdkn1bem2(IMPC)H |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
2.87×10-07 | |
Tmem203 Tmem203em1(IMPC)H |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.90×10-07 | |
Sar1b Sar1btm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
2.93×10-07 | |
Snx12 Snx12em1(IMPC)J |
HEM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.94×10-07 | |
C1qtnf1 C1qtnf1em1(IMPC)Mbp |
HOM | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.94×10-07 | |
Tnks Tnksem1(IMPC)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
2.99×10-07 | |
Hint1 Hint1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
3.01×10-07 | |
Nisch Nischtm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.03×10-07 | |
Msi2 Msi2em1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
3.08×10-07 | |
Elovl6 Elovl6tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
3.09×10-07 | |
Nab2 Nab2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.10×10-07 | |
Mysm1 Mysm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
3.10×10-07 | |
Unc119b Unc119btm1.1(KOMP)Vlcg |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
3.20×10-07 | |
Ahrr Ahrrtm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
3.23×10-07 | |
Ttll4 Ttll4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
3.24×10-07 | |
Rxrg RxrgRxrg |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
ICS EuroPhenome |
3.25×10-07 | |
Sdc1 Sdc1em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.31×10-07 | |
Zfp787 Zfp787em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
3.45×10-07 | |
Ywhab Ywhabtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
3.45×10-07 | |
Rint1 Rint1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
3.48×10-07 | |
Mindy1 Mindy1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI EuroPhenome |
3.59×10-07 | |
Ppil3 Ppil3tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.66×10-07 | |
Cc2d1b Cc2d1btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI EuroPhenome |
3.70×10-07 | |
Pcdhb13 Pcdhb13em1(IMPC)Tcp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
3.78×10-07 | |
Ctsa Ctsatm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.81×10-07 | |
Sdc2 Sdc2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
3.85×10-07 | |
Arr3 Arr3em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
3.99×10-07 | |
Atp8b1 Atp8b1em1(IMPC)Tcp |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
4.01×10-07 | |
Atg2b Atg2bem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.11×10-07 | |
Spns2 Spns2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
4.12×10-07 | |
Xbp1 Xbp1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU EuroPhenome |
4.17×10-07 | |
Dap Daptm1a(KOMP)Mbp |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
4.17×10-07 | |
Itgbl1 Itgbl1em1(IMPC)Kmpc |
HOM | Late adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
KMPC IMPC |
4.19×10-07 | |
Gc Gctm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
4.30×10-07 | |
Prkab1 Prkab1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.38×10-07 | |
Gda Gdatm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.41×10-07 | |
Sec16b Sec16btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.71×10-07 | |
Myzap Myzapem1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.71×10-07 | |
Sqstm1 Sqstm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.94×10-07 | |
Atad3a Atad3atm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.11×10-07 | |
Ago1 Ago1tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
5.14×10-07 | |
Slc6a3 Slc6a3tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.19×10-07 | |
Hnf4a Hnf4atm1b(EUCOMM)Hmgu |
HET | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.23×10-07 | |
4933434E20Rik 4933434E20Riktm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.29×10-07 | |
Baz1b Baz1btm2a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
5.45×10-07 | |
Elk3 Elk3em1(IMPC)Ics |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
5.61×10-07 | |
Heca Hecaem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.62×10-07 | |
Mgst1 Mgst1em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.67×10-07 | |
Cyp2c23 Cyp2c23tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.67×10-07 | |
Nodal Nodaltm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.80×10-07 | |
Vkorc1l1 Vkorc1l1em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
5.81×10-07 | |
Fbf1 Fbf1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.90×10-07 | |
Slc16a2 Slc16a2tm1a(KOMP)Wtsi |
HEM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
6.03×10-07 | |
Cdca7l Cdca7lem1(IMPC)Mbp |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
6.10×10-07 | |
Usp33 Usp33tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
6.14×10-07 | |
Shh Shhtm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.27×10-07 | |
Ggps1 Ggps1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
6.39×10-07 | |
Ap4e1 Ap4e1em1(IMPC)J |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
6.42×10-07 | |
Lonrf3 Lonrf3tm1a(KOMP)Wtsi |
HEM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
6.57×10-07 | |
Vil1 Vil1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
6.61×10-07 | |
Fgl1 Fgl1tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
6.81×10-07 | |
Insig1 Insig1em1(IMPC)Ccpcz |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
7.00×10-07 | |
Csmd3 Csmd3em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
7.03×10-07 | |
Secisbp2l Secisbp2lem1(IMPC)J |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.08×10-07 | |
Dennd5b Dennd5bem1(IMPC)Tcp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
7.12×10-07 | |
Cnot3 Cnot3em1(IMPC)Rbrc |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
RBRC IMPC |
7.17×10-07 | |
Sqstm1 Sqstm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
7.20×10-07 | |
Capn10 Capn10tm1b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
7.20×10-07 | |
Dbn1 Dbn1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
7.29×10-07 | |
Hmx3 Hmx3tm1Ebo |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
7.31×10-07 | |
Fam161a Fam161atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
7.40×10-07 | |
Spns2 Spns2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
7.41×10-07 | |
Cpgi15344 Cpgi15344tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
7.41×10-07 | |
Apmap Apmapem1(IMPC)J |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
7.44×10-07 | |
Plcg2 Plcg2Ali14 |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
HMGU EuroPhenome |
7.50×10-07 | |
Atxn7l2 Atxn7l2em1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
7.52×10-07 | |
Pdzk1 Pdzk1tm2b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
7.61×10-07 | |
Hspa5 Hspa5tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
7.65×10-07 | |
Grin3b Grin3btm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
7.65×10-07 | |
Nodal Nodaltm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
7.83×10-07 | |
Or9g4 Or9g4em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
7.90×10-07 | |
Txndc5 Txndc5tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
7.90×10-07 | |
Ap4e1 Ap4e1em1(IMPC)J |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
8.11×10-07 | |
Setd1a Setd1atm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
8.49×10-07 | |
Lrba Lrbaem1(IMPC)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
8.58×10-07 | |
Myo6 Myo6Tlc |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical chemistry (GMC) |
HMGU EuroPhenome |
8.59×10-07 | |
Cldn19 Cldn19tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
8.60×10-07 | |
Hdac7 Hdac7tm1b(EUCOMM)Hmgu |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
KMPC IMPC |
8.83×10-07 | |
Fam117b Fam117btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
8.86×10-07 | |
Cracdl Cracdltm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
8.92×10-07 | |
Lst1 Lst1tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
8.94×10-07 | |
Ift25 Ift25tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
WTSI EuroPhenome |
9.08×10-07 | |
H3f3b H3f3btm1.1(KOMP)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
9.11×10-07 | |
Cc2d1b Cc2d1btm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI EuroPhenome |
9.20×10-07 | |
Slc46a3 Slc46a3tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.32×10-07 | |
Sirt6 Sirt6tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell EuroPhenome |
9.40×10-07 | |
Hspb6 Hspb6em1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
9.70×10-07 | |
Ncapd3 Ncapd3em1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.84×10-07 | |
Mysm1 Mysm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
9.90×10-07 | |
Ct45a Ct45atm1e(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
9.94×10-07 | |
Rbpj Rbpjtm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
9.99×10-07 | |
Gc Gctm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.00×10-06 | |
Dll1 Dll1m1Mhda |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
HMGU EuroPhenome |
1.02×10-06 | |
Ing5 Ing5em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.02×10-06 | |
Nemf Nemftm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
1.05×10-06 | |
Smc5 Smc5tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.09×10-06 | |
Dbn1 Dbn1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
1.10×10-06 | |
Usp11 Usp11tm1(KOMP)Wtsi |
HEM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.11×10-06 | |
Dars2 Dars2tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.12×10-06 | |
Rwdd1 Rwdd1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
1.13×10-06 | |
Ikzf2 Ikzf2em2(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.14×10-06 | |
Vil1 Vil1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.14×10-06 | |
Mamld1 Mamld1tm1.1(NCOM)Mfgc |
HEM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
1.14×10-06 | |
Gpc4 Gpc4tm2b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.16×10-06 | |
Lrrk1 Lrrk1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.17×10-06 | |
Tmem129 Tmem129tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.17×10-06 | |
Arrb2 Arrb2tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.17×10-06 | |
Retreg3 Retreg3tm2b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.20×10-06 | |
Myzap Myzapem1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.20×10-06 | |
Dnajc10 Dnajc10tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.23×10-06 | |
Glra4 Glra4tm1b(KOMP)Wtsi |
HEM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.26×10-06 | |
Rab28 Rab28em1(IMPC)J |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.30×10-06 | |
Baat Baatem1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.31×10-06 | |
Kics2 Kics2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
1.32×10-06 | |
Pcsk5 Pcsk5tm1b(KOMP)Mbp |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
1.34×10-06 | |
Rfc1 Rfc1tm1b(KOMP)Mbp |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.35×10-06 | |
Zmym4 Zmym4em1(IMPC)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.35×10-06 | |
Kif26b Kif26btm2b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
1.35×10-06 | |
Stx6 Stx6em1(IMPC)H |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.36×10-06 | |
Appl2 Appl2tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.36×10-06 | |
Lepr Leprtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.36×10-06 | |
Pex3 Pex3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
1.36×10-06 | |
Alg1 Alg1tm1b(KOMP)Wtsi |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
MARC IMPC |
1.37×10-06 | |
Pcsk2 Pcsk2em1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.38×10-06 | |
Flvcr2 Flvcr2tm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.39×10-06 | |
Il2ra Il2ratm1b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
1.40×10-06 | |
Cpgi15344 Cpgi15344tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.41×10-06 | |
Sdha Sdhatm2b(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
1.42×10-06 | |
Ap2a2 Ap2a2em1(IMPC)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.43×10-06 | |
Sik1 Sik1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.43×10-06 | |
Tm9sf3 Tm9sf3em1(IMPC)Mbp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.45×10-06 | |
Il2ra Il2ratm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.46×10-06 | |
Asic1 Asic1em1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.46×10-06 | |
Cdc42 Cdc42tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.48×10-06 | |
Resp18 Resp18tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
1.49×10-06 | |
Xrcc5 Xrcc5em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
1.51×10-06 | |
Dnmt3a Dnmt3atm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
1.53×10-06 | |
Tbc1d22a Tbc1d22atm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.54×10-06 | |
Tnks Tnksem1(IMPC)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.57×10-06 | |
Fa2h Fa2hem1(IMPC)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.59×10-06 | |
Ctsa Ctsatm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.60×10-06 | |
Rec8 Rec8tm1b(KOMP)Wtsi |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.60×10-06 | |
Ankrd11 Ankrd11tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.62×10-06 | |
Abcg2 Abcg2tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.62×10-06 | |
Mettl16 Mettl16tm1b(KOMP)Mbp |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.63×10-06 | |
Gpr146 Gpr146em1(IMPC)H |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.65×10-06 | |
Ccnq Ccnqtm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.67×10-06 | |
Lrrk1 Lrrk1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.71×10-06 | |
Tmc6 Tmc6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.72×10-06 | |
Fbxo9 Fbxo9tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.75×10-06 | |
Kctd1 Kctd1em1(IMPC)J |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.76×10-06 | |
Ndufs1 Ndufs1tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
1.77×10-06 | |
Cenpo Cenpotm1b(KOMP)Mbp |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
1.85×10-06 | |
Elk4 Elk4tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
1.85×10-06 | |
Fgd5 Fgd5em1(IMPC)Mbp |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.89×10-06 | |
Pdcd6ip Pdcd6ipem1(IMPC)Mbp |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.89×10-06 | |
Dgki Dgkiem1(IMPC)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.94×10-06 | |
Rasal3 Rasal3tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
1.97×10-06 | |
Pls3 Pls3tm1a(EUCOMM)Wtsi |
HEM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
1.98×10-06 | |
Ube3b Ube3bGt(RRJ142)Byg |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
2.06×10-06 | |
Ntf5 Ntf5tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
2.11×10-06 | |
Camsap3 Camsap3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.12×10-06 | |
S2bpcox16 S2bpcox16em1(IMPC)J |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.12×10-06 | |
Cib2 Cib2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.14×10-06 | |
Yae1d1 Yae1d1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
2.16×10-06 | |
Arrb2 Arrb2tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
2.22×10-06 | |
Slc40a1 Slc40a1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
2.23×10-06 | |
Taco1 Taco1em1(IMPC)J |
HOM | Late adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.23×10-06 | |
Dusp7 Dusp7tm1(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
2.27×10-06 | |
Hbp1 Hbp1not yet available |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
2.35×10-06 | |
Casq1 Casq1tm1b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
2.40×10-06 | |
Sdc1 Sdc1em1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.41×10-06 | |
Col18a1 Col18a1tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Plasma Chemistry |
JAX IMPC |
2.46×10-06 | |
Fkbp4 Fkbp4em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
2.47×10-06 | |
Wnt1 Wnt1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.56×10-06 | |
Tagap1 Tagap1em1(IMPC)Tcp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
2.56×10-06 | |
Wrap53 Wrap53tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.58×10-06 | |
Zfp84 Zfp84tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.58×10-06 | |
Rhag Rhagem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
2.61×10-06 | |
Rnf14 Rnf14em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
2.65×10-06 | |
Rapsn Rapsntm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.68×10-06 | |
Dbnl Dbnltm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
2.76×10-06 | |
Map3k10 Map3k10tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
2.79×10-06 | |
Dync1i2 Dync1i2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
2.81×10-06 | |
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
2.85×10-06 | |
Zfp175 Zfp175tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.85×10-06 | |
C1qtnf1 C1qtnf1em1(IMPC)Mbp |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
2.90×10-06 | |
Snx6 Snx6em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.95×10-06 | |
Trim8 Trim8em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.09×10-06 | |
Ccdc18 Ccdc18tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.10×10-06 | |
Arrb2 Arrb2tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.14×10-06 | |
Atp11c Atp11cem1(IMPC)J |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.16×10-06 | |
Aspm Aspmtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.16×10-06 | |
Edem1 Edem1em1(IMPC)Kmpc |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
KMPC IMPC |
3.16×10-06 | |
Sla2 Sla2em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
3.18×10-06 | |
Diaph3 Diaph3tm1b(KOMP)Mbp |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
3.19×10-06 | |
Acsl5 Acsl5tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
3.19×10-06 | |
Zmym4 Zmym4em1(IMPC)Wtsi |
HET | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.20×10-06 | |
Sorbs2 Sorbs2tm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.23×10-06 | |
Usp11 Usp11tm1(KOMP)Wtsi |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.26×10-06 | |
Gcgr Gcgrtm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
3.28×10-06 | |
Sgo1 Sgo1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
3.30×10-06 | |
Lyn Lyntm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
3.31×10-06 | |
Cyb5d1 Cyb5d1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.33×10-06 | |
Aspn Aspntm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
3.35×10-06 | |
Gys2 Gys2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
WTSI EuroPhenome |
3.36×10-06 | |
Syce1l Syce1ltm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
3.40×10-06 | |
Fbxl5 Fbxl5em1(IMPC)Marc |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
3.53×10-06 | |
Tbc1d9b Tbc1d9bem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.55×10-06 | |
Vcpkmt Vcpkmttm1.1(KOMP)Vlcg |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
3.55×10-06 | |
Zfp637 Zfp637em1(IMPC)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
3.56×10-06 | |
Rnf4 Rnf4em1(IMPC)Ccpcz |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
3.58×10-06 | |
Enc1 Enc1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.63×10-06 | |
Pax5 Pax5tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
3.64×10-06 | |
Phf8 Phf8em2(IMPC)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.69×10-06 | |
Rpa1 Rpa1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.69×10-06 | |
Bcorl1 Bcorl1em1(IMPC)Tcp |
HEM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
3.80×10-06 | |
Col6a3 Col6a3em1(IMPC)Kmpc |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
KMPC IMPC |
3.91×10-06 | |
Arhgef4 Arhgef4tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI EuroPhenome |
3.94×10-06 | |
Clpp Clpptm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.95×10-06 | |
Dtx1 Dtx1em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.10×10-06 | |
Ptcd3 Ptcd3tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.17×10-06 | |
Pom121l2 Pom121l2em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.20×10-06 | |
Entr1 Entr1em1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.24×10-06 | |
Lrba Lrbaem1(IMPC)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.29×10-06 | |
Hspb6 Hspb6em1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.33×10-06 | |
Dusp26 Dusp26tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.37×10-06 | |
Gc Gctm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
4.44×10-06 | |
Hprt1 Hprt1tm1a(EUCOMM)Hmgu |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
4.49×10-06 | |
Ndufs3 Ndufs3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.51×10-06 | |
Snf8 Snf8tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
MRC Harwell MGP |
4.56×10-06 | |
Ccl9 Ccl9tm1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.56×10-06 | |
Myo18b Myo18bem2(IMPC)Ics |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
4.57×10-06 | |
Ggps1 Ggps1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
4.60×10-06 | |
Pllp Pllptm1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
4.67×10-06 | |
Slc10a3 Slc10a3em1(IMPC)J |
HEM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.70×10-06 | |
Fndc7 Fndc7tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
4.71×10-06 | |
Celsr1 Celsr1Scy |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
4.78×10-06 | |
Abcc2 Abcc2tm2b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.80×10-06 | |
Dop1b Dop1btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
4.81×10-06 | |
Trim56 Trim56tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.83×10-06 | |
Trmt10a Trmt10atm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
4.92×10-06 | |
Btbd16 Btbd16tm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
BCM IMPC |
4.93×10-06 | |
Ndufs3 Ndufs3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
4.93×10-06 | |
Gm94 Gm94tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.94×10-06 | |
Stk32a Stk32atm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
4.94×10-06 | |
Mettl16 Mettl16tm1b(KOMP)Mbp |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.96×10-06 | |
Sla2 Sla2em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
4.96×10-06 | |
Klhl5 Klhl5tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
4.98×10-06 | |
Aqp1 Aqp1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.00×10-06 | |
Dgkk Dgkkem1(IMPC)Ics |
HEM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
5.02×10-06 | |
Rc3h2 Rc3h2tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.05×10-06 | |
Nsmce1 Nsmce1em1(IMPC)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
5.06×10-06 | |
4933434E20Rik 4933434E20Riktm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.07×10-06 | |
Cbx6 Cbx6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.10×10-06 | |
Rbm14 Rbm14tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.13×10-06 | |
Tsga13 Tsga13em1(IMPC)J |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
5.18×10-06 | |
Bloc1s2 Bloc1s2tm1.1(KOMP)Mbp |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.23×10-06 | |
Ints6l Ints6lem1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
5.31×10-06 | |
Gde1 Gde1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.32×10-06 | |
Tex261 Tex261tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.33×10-06 | |
Bcorl1 Bcorl1em1(IMPC)Tcp |
HEM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
5.37×10-06 | |
Tmem9b Tmem9bem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
5.39×10-06 | |
Krtap17-1 Krtap17-1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
5.40×10-06 | |
Hspb3 Hspb3tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.41×10-06 | |
Zfp202 Zfp202em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.42×10-06 | |
Cd200 Cd200tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
5.52×10-06 | |
Dscc1 Dscc1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
5.56×10-06 | |
Slc24a4 Slc24a4tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.62×10-06 | |
Sidt2 Sidt2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
5.68×10-06 | |
Dpy19l3 Dpy19l3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
ICS EuroPhenome |
5.71×10-06 | |
Slc7a2 Slc7a2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.75×10-06 | |
Slc38a2 Slc38a2tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.81×10-06 | |
Nab1 Nab1em1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.82×10-06 | |
Plekhf2 Plekhf2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.91×10-06 | |
Ms4a4d Ms4a4dem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.93×10-06 | |
Ufm1 Ufm1em1(IMPC)Marc |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
5.94×10-06 | |
Col18a1 Col18a1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
5.97×10-06 | |
Dusp7 Dusp7tm1(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
MARC IMPC |
5.98×10-06 | |
Cracdl Cracdltm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.01×10-06 | |
Rhd Rhdtm1e(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
6.09×10-06 | |
Plxnc1 Plxnc1em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
6.12×10-06 | |
Atad3a Atad3atm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.13×10-06 | |
Ift25 Ift25tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
6.21×10-06 | |
Amfr Amfrtm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
6.23×10-06 | |
Dusp26 Dusp26tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
6.23×10-06 | |
Trim56 Trim56tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
6.28×10-06 | |
Chrna7 Chrna7tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.33×10-06 | |
Col9a2 Col9a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
6.33×10-06 | |
Rbl2 Rbl2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.39×10-06 | |
Rrbp1 Rrbp1em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
6.54×10-06 | |
Polr2h Polr2htm1.1(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
6.63×10-06 | |
Ephx1 Ephx1Ephx1 |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
6.65×10-06 | |
Chn1 Chn1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
6.66×10-06 | |
Pttg1 Pttg1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
6.72×10-06 | |
Or9g4 Or9g4em1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
6.73×10-06 | |
Lactb Lactbtm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
6.76×10-06 | |
Igfals Igfalstm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
6.76×10-06 | |
Kat8 Kat8em1(IMPC)Mbp |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
6.88×10-06 | |
Ska2 Ska2tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
6.88×10-06 | |
Ccl9 Ccl9tm1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
6.92×10-06 | |
Mbtd1 Mbtd1tm2a(EUCOMM)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
6.96×10-06 | |
Snx8 Snx8tm2a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.05×10-06 | |
Prdm12 Prdm12tm2b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
7.07×10-06 | |
Prkcz Prkcztm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
7.07×10-06 | |
Clpp Clpptm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
7.09×10-06 | |
Rras Rrasem1(IMPC)H |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
7.10×10-06 | |
Hspa5 Hspa5tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
7.12×10-06 | |
Micos13 Micos13tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
7.19×10-06 | |
Cyp27a1 Cyp27a1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
7.23×10-06 | |
Fgf20 Fgf20em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
7.37×10-06 | |
Csnk2a2 Csnk2a2em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
7.37×10-06 | |
Mcu Mcutm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.40×10-06 | |
Elk4 Elk4tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI EuroPhenome |
7.47×10-06 | |
Rnf25 Rnf25tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
7.58×10-06 | |
Pcsk5 Pcsk5tm1b(KOMP)Mbp |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
7.64×10-06 | |
Nab1 Nab1em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.71×10-06 | |
Grhl3 Grhl3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
7.71×10-06 | |
Ttc17 Ttc17em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.72×10-06 | |
Slc24a4 Slc24a4tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.77×10-06 | |
Tpgs2 Tpgs2tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
7.77×10-06 | |
Gm28050 Gm28050tm1.1(NCC)WCS |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
7.82×10-06 | |
Fam110b Fam110btm1e(EUCOMM)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
HMGU EuroPhenome |
7.83×10-06 | |
Fam117b Fam117btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
8.12×10-06 | |
Ntf5 Ntf5tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
8.15×10-06 | |
Phf11a Phf11atm1b(NCOM)Mfgc |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
8.24×10-06 | |
Cyb561 Cyb561tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.31×10-06 | |
Trmt10a Trmt10atm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI MGP |
8.33×10-06 | |
Gfpt1 Gfpt1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.38×10-06 | |
0610040J01Rik 0610040J01Rikem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
8.55×10-06 | |
Cdk12 Cdk12em1(IMPC)Tcp |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
8.57×10-06 | |
Zfp763 Zfp763em1(IMPC)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
8.60×10-06 | |
Cntfr Cntfrtm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
8.61×10-06 | |
Cyp27a1 Cyp27a1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
8.63×10-06 | |
Anapc15 Anapc15tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.73×10-06 | |
Spns2 Spns2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
8.86×10-06 | |
Sorbs2 Sorbs2tm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
8.89×10-06 | |
Trmt1 Trmt1tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
9.00×10-06 | |
D6Wsu163e D6Wsu163etm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
9.00×10-06 | |
Pdzd8 Pdzd8tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
9.03×10-06 | |
Sidt2 Sidt2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
9.06×10-06 | |
Tmc1 Tmc1Bth |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical chemistry (GMC) |
HMGU EuroPhenome |
9.21×10-06 | |
Bnip3 Bnip3em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
9.36×10-06 | |
Celsr1 Celsr1Scy |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
9.37×10-06 | |
Elmod1 Elmod1tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
9.48×10-06 | |
Ces3b Ces3bem1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
9.55×10-06 | |
Prr5 Prr5em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.64×10-06 | |
Smyd2 Smyd2tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
9.68×10-06 | |
Mtarc2 Mtarc2tm2a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
ICS EuroPhenome |
9.70×10-06 | |
Sh3tc1 Sh3tc1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
9.88×10-06 | |
Krtap17-1 Krtap17-1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
9.92×10-06 | |
Cib2 Cib2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.99×10-06 | |
Heca Hecaem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.01×10-05 | |
Fgf10 Fgf10tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.01×10-05 | |
Bhlhe40 Bhlhe40tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.01×10-05 | |
Atn1 Atn1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.02×10-05 | |
Slc16a2 Slc16a2tm1a(KOMP)Wtsi |
HEM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.03×10-05 | |
Rnf7 Rnf7tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
1.04×10-05 | |
Cdc20b Cdc20bem1(IMPC)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
1.04×10-05 | |
Alad Aladem1(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
1.05×10-05 | |
Mdk Mdktm1.1(KOMP)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.05×10-05 | |
Itm2c Itm2cem2(IMPC)Tcp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
1.05×10-05 | |
Shld1 Shld1em1(IMPC)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
1.07×10-05 | |
Ngdn Ngdntm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.07×10-05 | |
Gulo Guloem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
1.07×10-05 | |
Mmp11 Mmp11tm1a(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.09×10-05 | |
Hbs1l Hbs1ltm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.09×10-05 | |
Cyp7a1 Cyp7a1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.09×10-05 | |
Sqstm1 Sqstm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.11×10-05 | |
C4bp C4bptm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.11×10-05 | |
Fgd4 Fgd4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.12×10-05 | |
Pax7 Pax7tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Plasma Chemistry |
JAX IMPC |
1.12×10-05 | |
Tctn3 Tctn3em1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.12×10-05 | |
Pitx3 Pitx3eyl |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical chemistry (GMC) |
HMGU EuroPhenome |
1.13×10-05 | |
Elk4 Elk4tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.13×10-05 | |
Aqp1 Aqp1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.13×10-05 | |
Pdzk1 Pdzk1tm2b(EUCOMM)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.13×10-05 | |
Ak4 Ak4em1(IMPC)Kmpc |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
KMPC IMPC |
1.14×10-05 | |
Phf8 Phf8tm1dIcs |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
1.14×10-05 | |
Ccdc92 Ccdc92tm1b(KOMP)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.14×10-05 | |
Entpd1 Entpd1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.14×10-05 | |
Lpcat2 Lpcat2em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.15×10-05 | |
Irgm1 Irgm1em1(IMPC)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.15×10-05 | |
Sesn3 Sesn3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.16×10-05 | |
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.16×10-05 | |
Tmc7 Tmc7em1(IMPC)Mbp |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.17×10-05 | |
Ppme1 Ppme1em1(IMPC)Rbrc |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
RBRC IMPC |
1.17×10-05 | |
Setd1b Setd1btm1.2(IMPC)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.17×10-05 | |
Rgp1 Rgp1tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
1.17×10-05 | |
Tm9sf4 Tm9sf4tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.19×10-05 | |
Acbd3 Acbd3tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
1.20×10-05 | |
Atp11a Atp11atm1e(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.21×10-05 | |
Grm3 Grm3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.22×10-05 | |
Aqp3 Aqp3tm2b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.22×10-05 | |
Mtrf1l Mtrf1ltm1a(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
1.23×10-05 | |
1700008P02Rik 1700008P02Rikem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.24×10-05 | |
Dlg2 Dlg2tm1Dsb |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
1.24×10-05 | |
Prkd3 Prkd3tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.27×10-05 | |
Cidec Cidectm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.27×10-05 | |
Fam161a Fam161atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
1.29×10-05 | |
Dop1b Dop1btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.30×10-05 | |
Rhd Rhdtm1e(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI EuroPhenome |
1.31×10-05 | |
Ermn Ermnem1(IMPC)H |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.31×10-05 | |
Zmym4 Zmym4em1(IMPC)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.32×10-05 | |
Ydjc Ydjctm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.34×10-05 | |
Csnk2a2 Csnk2a2em1(IMPC)Mbp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.35×10-05 | |
Tagap1 Tagap1em1(IMPC)Tcp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
1.35×10-05 | |
Tpcn2 Tpcn2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.36×10-05 | |
Banp Banpem1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.37×10-05 | |
Fhl1 Fhl1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.37×10-05 | |
Otud6a Otud6atm1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
1.37×10-05 | |
Plxna4 Plxna4em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
1.39×10-05 | |
Fbf1 Fbf1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.40×10-05 | |
Tox Toxtm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.40×10-05 | |
Rnf180 Rnf180em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
1.43×10-05 | |
Wdr27 Wdr27em1(IMPC)Ccpcz |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
1.43×10-05 | |
Rnf10 Rnf10tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
1.43×10-05 | |
Cdc42 Cdc42tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.45×10-05 | |
Gemin4 Gemin4em1(IMPC)Ics |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
1.45×10-05 | |
Cenph Cenphtm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.46×10-05 | |
Ms4a4d Ms4a4dem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.46×10-05 | |
Nup205 Nup205em1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.46×10-05 | |
Phf8 Phf8em2(IMPC)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.46×10-05 | |
Slain2 Slain2em1(IMPC)J |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.50×10-05 | |
Runx1t1 Runx1t1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
1.50×10-05 | |
Enc1 Enc1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.51×10-05 | |
Slc5a5 Slc5a5tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.51×10-05 | |
Ppp2r5c Ppp2r5cem1(IMPC)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
1.52×10-05 | |
Nfkbid Nfkbidtm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.52×10-05 | |
Map3k1 Map3k1tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
1.52×10-05 | |
Ankrd12 Ankrd12tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell EuroPhenome |
1.53×10-05 | |
Trmo Trmotm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI MGP |
1.54×10-05 | |
Flvcr2 Flvcr2tm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.54×10-05 | |
Ltk Ltkem1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.54×10-05 | |
Atp11c Atp11cem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.55×10-05 | |
Ago1 Ago1tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
1.56×10-05 | |
Krt7 Krt7tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.57×10-05 | |
Bzw2 Bzw2tm1b(KOMP)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
1.57×10-05 | |
Hells Hellstm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.59×10-05 | |
Pkn2 Pkn2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.59×10-05 | |
Tspan17 Tspan17em1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.59×10-05 | |
Alg8 Alg8em1(IMPC)J |
HET | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.59×10-05 | |
Rilpl2 Rilpl2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
1.60×10-05 | |
Prmt1 Prmt1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.60×10-05 | |
Dbnl Dbnltm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
1.61×10-05 | |
Ube3b Ube3bGt(RRJ142)Byg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
1.62×10-05 | |
Rbm14 Rbm14tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.63×10-05 | |
Plekhf2 Plekhf2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.64×10-05 | |
Syne3 Syne3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.64×10-05 | |
D6Wsu163e D6Wsu163etm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.64×10-05 | |
Rc3h2 Rc3h2tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.67×10-05 | |
Fstl1 Fstl1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.67×10-05 | |
Ddx51 Ddx51tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
1.67×10-05 | |
Fam83g Fam83gtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
1.68×10-05 | |
Adgrf5 Adgrf5tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.69×10-05 | |
Setd1b Setd1btm1.2(IMPC)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.69×10-05 | |
Osbpl11 Osbpl11tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
1.70×10-05 | |
Oxtr Oxtrtm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
RBRC IMPC |
1.70×10-05 | |
Elk4 Elk4tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
1.71×10-05 | |
Gna14 Gna14em1(IMPC)Kmpc |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
KMPC IMPC |
1.71×10-05 | |
Pdzk1 Pdzk1tm2b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.71×10-05 | |
Pnpt1 Pnpt1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
1.72×10-05 | |
Actr6 Actr6tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
1.72×10-05 | |
Slc29a3 Slc29a3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
1.72×10-05 | |
Kash5 Kash5em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.72×10-05 | |
Kat2b Kat2bem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.73×10-05 | |
Cyfip1 Cyfip1tm2a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.74×10-05 | |
Tmod1 Tmod1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
1.74×10-05 | |
Rhd Rhdtm1e(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.74×10-05 | |
Otud6a Otud6atm1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MARC IMPC |
1.75×10-05 | |
Firrm Firrmtm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.77×10-05 | |
Usp53 Usp53em1(IMPC)Tcp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
1.78×10-05 | |
Rab43 Rab43tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
1.78×10-05 | |
Zfp697 Zfp697em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.79×10-05 | |
Pom121l2 Pom121l2em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
1.80×10-05 | |
Parvb Parvbtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell EuroPhenome |
1.81×10-05 | |
Kcnab3 Kcnab3tm1.1(KOMP)Vlcg |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
1.81×10-05 | |
Atp11a Atp11atm1e(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.81×10-05 | |
Ppil3 Ppil3tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.82×10-05 | |
Cc2d1b Cc2d1btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
WTSI EuroPhenome |
1.83×10-05 | |
Spryd3 Spryd3tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
1.85×10-05 | |
Pdpn Pdpntm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.86×10-05 | |
Ska2 Ska2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.86×10-05 | |
Dnase2b Dnase2btm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
1.86×10-05 | |
Mat2a Mat2atm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
1.89×10-05 | |
Sclt1 Sclt1em1(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
1.89×10-05 | |
Aspn Aspntm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
1.92×10-05 | |
Cmpk2 Cmpk2tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
1.93×10-05 | |
Micos13 Micos13tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.94×10-05 | |
Wrap53 Wrap53tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
1.95×10-05 | |
Hmx3 Hmx3tm1Ebo |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
1.95×10-05 | |
Msto1 Msto1em1(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
1.96×10-05 | |
Dsg1c Dsg1cem1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
1.96×10-05 | |
Arhgef4 Arhgef4tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
1.97×10-05 | |
Npcd Npcdem1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
1.99×10-05 | |
Il17rc Il17rcem1(IMPC)Mbp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
1.99×10-05 | |
Tnks Tnksem1(IMPC)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
2.02×10-05 | |
Rnf10 Rnf10tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
2.02×10-05 | |
Mdm1 Mdm1em1(IMPC)Kmpc |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
KMPC IMPC |
2.03×10-05 | |
Aspm Aspmtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.03×10-05 | |
Cpd Cpdem1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.04×10-05 | |
Pik3ap1 Pik3ap1tm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
2.05×10-05 | |
Lca5l Lca5lem1(IMPC)Ics |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
2.07×10-05 | |
Ccdc18 Ccdc18tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
2.08×10-05 | |
Atad2b Atad2btm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
2.08×10-05 | |
Tmem9b Tmem9bem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.09×10-05 | |
Dock9 Dock9em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.10×10-05 | |
Tial1 Tial1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
2.15×10-05 | |
Emcn Emcnem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.15×10-05 | |
Snx8 Snx8tm2a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.16×10-05 | |
L3mbtl3 L3mbtl3em2(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
2.17×10-05 | |
Il12a Il12atm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.18×10-05 | |
Sidt2 Sidt2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.19×10-05 | |
Pon3 Pon3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
KMPC IMPC |
2.19×10-05 | |
Acan Acantm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.22×10-05 | |
Gnasas1 Gnasas1tm2.1Jop |
HET | Early adult | increased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.22×10-05 | |
Scrib Scribtm1b(NCOM)Mfgc |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
2.25×10-05 | |
Rbm20 Rbm20em1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
2.25×10-05 | |
Hbs1l Hbs1ltm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.26×10-05 | |
Nepn Nepntm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
2.26×10-05 | |
Atp13a3 Atp13a3em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.27×10-05 | |
Firrm Firrmtm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.27×10-05 | |
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
RBRC IMPC |
2.28×10-05 | |
Jakmip3 Jakmip3em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.30×10-05 | |
Dnajc2 Dnajc2em1(IMPC)J |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.33×10-05 | |
Slc39a8 Slc39a8tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
2.38×10-05 | |
Map3k10 Map3k10tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
2.38×10-05 | |
Eftud2 Eftud2tm1b(KOMP)Wtsi |
HET | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
2.40×10-05 | |
P2rx7 P2rx7tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
HMGU EuroPhenome |
2.41×10-05 | |
Resp18 Resp18tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
2.41×10-05 | |
Gnasas1 Gnasas1tm2.1Jop |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.44×10-05 | |
Atg4b Atg4btm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.46×10-05 | |
Rab36 Rab36tm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.47×10-05 | |
Usp46 Usp46em1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
2.47×10-05 | |
Ensa Ensaem1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
2.48×10-05 | |
Brwd1 Brwd1em1(IMPC)Tcp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
2.48×10-05 | |
Usp46 Usp46em1(IMPC)Marc |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MARC IMPC |
2.52×10-05 | |
Ubash3a Ubash3atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
2.53×10-05 | |
Etv6 Etv6em1(IMPC)Rbrc |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
RBRC IMPC |
2.53×10-05 | |
Atg4b Atg4btm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.56×10-05 | |
Gpld1 Gpld1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.57×10-05 | |
Acot5 Acot5tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
2.59×10-05 | |
Ncapd3 Ncapd3em1(IMPC)J |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.60×10-05 | |
C2cd4b C2cd4bem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.61×10-05 | |
Wdtc1 Wdtc1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
2.62×10-05 | |
Abcb4 Abcb4em1(IMPC)H |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.63×10-05 | |
Stag1 Stag1em1(IMPC)Mbp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
2.64×10-05 | |
Fgl1 Fgl1tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
2.64×10-05 | |
Ska2 Ska2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
2.65×10-05 | |
Arhgef4 Arhgef4tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
HMGU EuroPhenome |
2.65×10-05 | |
Otc Otcem1(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
2.69×10-05 | |
Tfec Tfectm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
2.70×10-05 | |
Ehmt1 Ehmt1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.70×10-05 | |
Cenpo Cenpotm1b(KOMP)Mbp |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Plasma Chemistry |
JAX IMPC |
2.73×10-05 | |
Kat2b Kat2bem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.73×10-05 | |
Gpr146 Gpr146em1(IMPC)H |
HOM | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
2.74×10-05 | |
Or1e32 Or1e32em1(IMPC)Mbp |
HOM | Late adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
2.74×10-05 | |
Rab5a Rab5atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
2.75×10-05 | |
Cyp17a1 Cyp17a1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MARC IMPC |
2.77×10-05 | |
Wdr53 Wdr53em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.77×10-05 | |
Pcdhb13 Pcdhb13em1(IMPC)Tcp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
2.77×10-05 | |
Rnf180 Rnf180em1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
2.80×10-05 | |
Pck2 Pck2em1(IMPC)Tcp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
2.81×10-05 | |
Car7 Car7tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
2.81×10-05 | |
Kif2c Kif2ctm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
RBRC IMPC |
2.85×10-05 | |
Ghrhr Ghrhrtm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Plasma Chemistry |
JAX IMPC |
2.87×10-05 | |
Ppp2r2b Ppp2r2btm1b(KOMP)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
2.87×10-05 | |
Lonp1 Lonp1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
2.87×10-05 | |
Clock Clockem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
2.87×10-05 | |
Pm20d1 Pm20d1em1(IMPC)H |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
2.88×10-05 | |
Vangl2 Vangl2Lp |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.88×10-05 | |
Bok Boktm1b(EUCOMM)Hmgu |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
2.89×10-05 | |
Bhlhe40 Bhlhe40tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
2.89×10-05 | |
Rrbp1 Rrbp1em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
2.90×10-05 | |
Pde1a Pde1aem1(IMPC)H |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
2.90×10-05 | |
C2cd4b C2cd4bem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
2.90×10-05 | |
Txndc5 Txndc5tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
2.93×10-05 | |
Rnf25 Rnf25tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
2.93×10-05 | |
Zbtb32 Zbtb32tm1b(KOMP)Mbp |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
2.93×10-05 | |
Entpd1 Entpd1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
2.94×10-05 | |
Fgf10 Fgf10tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.00×10-05 | |
Cdh9 Cdh9tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.02×10-05 | |
Kpna2 Kpna2em1(IMPC)Mbp |
HET | Late adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
3.03×10-05 | |
Nptn Nptntm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.03×10-05 | |
Gramd1c Gramd1ctm1b(KOMP)Wtsi |
HOM | Late adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
3.04×10-05 | |
Igfals Igfalstm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
3.04×10-05 | |
Abcb11 Abcb11tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
3.05×10-05 | |
Zzef1 Zzef1tm2.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
3.08×10-05 | |
Mgst1 Mgst1em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.08×10-05 | |
Dnmt3a Dnmt3atm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
3.10×10-05 | |
Setbp1 Setbp1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.11×10-05 | |
Osm Osmtm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.20×10-05 | |
Ehd1 Ehd1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.20×10-05 | |
Fam210a Fam210atm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
3.21×10-05 | |
Ttc39b Ttc39btm1e(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
WTSI EuroPhenome |
3.21×10-05 | |
Mcu Mcutm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.21×10-05 | |
Prkd3 Prkd3tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
3.22×10-05 | |
Alg8 Alg8em1(IMPC)J |
HET | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.22×10-05 | |
Sec24a Sec24atm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
3.23×10-05 | |
Ift25 Ift25tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
WTSI EuroPhenome |
3.23×10-05 | |
Sgo1 Sgo1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
3.24×10-05 | |
Sorbs2 Sorbs2tm1.1(KOMP)Mbp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
3.24×10-05 | |
Vps33b Vps33btm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.25×10-05 | |
Smyd4 Smyd4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI MGP |
3.27×10-05 | |
Cybc1 Cybc1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
3.27×10-05 | |
Kif21b Kif21btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.28×10-05 | |
Drg2 Drg2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
ICS EuroPhenome |
3.29×10-05 | |
Morc2a Morc2aem1(IMPC)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.29×10-05 | |
Pigh Pightm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
3.29×10-05 | |
Cyp27a1 Cyp27a1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
3.31×10-05 | |
Dnajc9 Dnajc9tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
3.32×10-05 | |
Taf2 Taf2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.32×10-05 | |
Wdr41 Wdr41em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.34×10-05 | |
Cstf1 Cstf1em1(IMPC)J |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
3.35×10-05 | |
Adamts16 Adamts16em1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.36×10-05 | |
Cygb Cygbtm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
3.36×10-05 | |
Gemin4 Gemin4em1(IMPC)Ics |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.37×10-05 | |
Abhd8 Abhd8tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
BCM IMPC |
3.38×10-05 | |
Camsap3 Camsap3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.40×10-05 | |
Cps1 Cps1em1(IMPC)H |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.40×10-05 | |
Wac Wactm2b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
3.46×10-05 | |
Abcg2 Abcg2tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.46×10-05 | |
Usp26 Usp26em1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
3.49×10-05 | |
Asxl2 Asxl2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
3.49×10-05 | |
Tmem51 Tmem51tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.51×10-05 | |
Cntn3 Cntn3em1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
3.51×10-05 | |
Myh7b Myh7btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.52×10-05 | |
Tmem248 Tmem248tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
3.53×10-05 | |
Tm9sf4 Tm9sf4tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.55×10-05 | |
Phex Phexnot yet available |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
HMGU EuroPhenome |
3.55×10-05 | |
Trub2 Trub2tm2a(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
3.56×10-05 | |
Aldh2 Aldh2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU EuroPhenome |
3.57×10-05 | |
Nxn Nxntm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
3.57×10-05 | |
S2bpcox16 S2bpcox16em1(IMPC)J |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.57×10-05 | |
Lyn Lyntm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.58×10-05 | |
Rnf10 Rnf10tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
3.59×10-05 | |
Nexmif Nexmifem1(IMPC)Tcp |
HEM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
3.61×10-05 | |
Anxa6 Anxa6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
3.62×10-05 | |
Nodal Nodaltm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.64×10-05 | |
Prep Preptm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.65×10-05 | |
Nxn Nxntm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
CCP-IMG IMPC |
3.65×10-05 | |
Susd6 Susd6tm1b(KOMP)Wtsi |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.67×10-05 | |
Cibar1 Cibar1tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.67×10-05 | |
Slc10a3 Slc10a3em1(IMPC)J |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.69×10-05 | |
Pld5 Pld5tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.71×10-05 | |
Cpgi15344 Cpgi15344tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.71×10-05 | |
Rpia Rpiatm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
3.72×10-05 | |
Col5a1 Col5a1tm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
ICS EuroPhenome |
3.74×10-05 | |
Phf8 Phf8em2(IMPC)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.75×10-05 | |
Grm3 Grm3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.76×10-05 | |
Mysm1 Mysm1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
3.76×10-05 | |
Msx1 Msx1tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
3.77×10-05 | |
Abhd14a Abhd14atm2a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.79×10-05 | |
Wdr53 Wdr53em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
3.79×10-05 | |
Pkn2 Pkn2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
3.80×10-05 | |
Tecr Tecrem1(IMPC)Rbrc |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
RBRC IMPC |
3.80×10-05 | |
Padi4 Padi4em1(IMPC)Mbp |
HOM | Late adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
3.83×10-05 | |
Fbf1 Fbf1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.87×10-05 | |
Krt7 Krt7tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
3.89×10-05 | |
Tmem42 Tmem42tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
3.89×10-05 | |
Pik3c3 Pik3c3tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
ICS EuroPhenome |
3.90×10-05 | |
Cacna2d3 Cacna2d3tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Plasma Chemistry |
JAX IMPC |
3.92×10-05 | |
Gulo Guloem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
3.93×10-05 | |
Prkra Prkraem1(IMPC)H |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
3.94×10-05 | |
Vkorc1l1 Vkorc1l1em1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
3.94×10-05 | |
Pitx3 Pitx3tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.97×10-05 | |
Cacna2d3 Cacna2d3tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
3.99×10-05 | |
Raly Ralyem2(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
4.00×10-05 | |
Lmod3 Lmod3em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
4.02×10-05 | |
Becn1 Becn1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
4.03×10-05 | |
Pttg1 Pttg1tm1b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
4.03×10-05 | |
Cldn23 Cldn23em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
4.04×10-05 | |
Kif18b Kif18btm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
4.06×10-05 | |
Fstl1 Fstl1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.06×10-05 | |
Rab36 Rab36tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL cholesterol Plasma Chemistry |
JAX IMPC |
4.08×10-05 | |
Nelfcd Nelfcdem1(IMPC)J |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.08×10-05 | |
Aspm Aspmtm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
4.11×10-05 | |
Tmem87b Tmem87bem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.13×10-05 | |
Impact Impactem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
4.15×10-05 | |
Nr0b1 Nr0b1em2(IMPC)Wtsi |
HEM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.20×10-05 | |
Flvcr2 Flvcr2tm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.20×10-05 | |
Trip13 Trip13tm1.1(KOMP)Vlcg |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.24×10-05 | |
Cldnd2 Cldnd2tm1b(EUCOMM)Hmgu |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
4.26×10-05 | |
Cdca8 Cdca8tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.30×10-05 | |
Wdr47 Wdr47tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
4.31×10-05 | |
Tm9sf4 Tm9sf4tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.32×10-05 | |
Ncald Ncaldtm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
4.33×10-05 | |
Lyn Lyntm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.34×10-05 | |
Mgrn1 Mgrn1em1(IMPC)Tcp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
4.35×10-05 | |
Tgfb1i1 Tgfb1i1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.37×10-05 | |
Cul7 Cul7tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
4.39×10-05 | |
Aqp3 Aqp3tm2b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.39×10-05 | |
Dnajc10 Dnajc10tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
4.39×10-05 | |
Clcn1 Clcn1em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.43×10-05 | |
Dscc1 Dscc1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.44×10-05 | |
Ube2d1 Ube2d1tm3e(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.46×10-05 | |
Dock10 Dock10tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU EuroPhenome |
4.47×10-05 | |
Arid3a Arid3atm1b(KOMP)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
4.47×10-05 | |
Txndc11 Txndc11em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.50×10-05 | |
Ube3b Ube3bGt(RRJ142)Byg |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
4.52×10-05 | |
Dmxl2 Dmxl2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.53×10-05 | |
Plxnc1 Plxnc1em1(IMPC)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.53×10-05 | |
Tbx22 Tbx22tm1.1(KOMP)Vlcg |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.54×10-05 | |
Lmod3 Lmod3em1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
4.56×10-05 | |
Zzef1 Zzef1tm2.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
4.57×10-05 | |
Wdr45 Wdr45em1(IMPC)J |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.59×10-05 | |
Carmil2 Carmil2tm1b(KOMP)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
4.62×10-05 | |
Fgf20 Fgf20em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
4.67×10-05 | |
Tbc1d9b Tbc1d9bem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.68×10-05 | |
Mtrf1 Mtrf1tm1a(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
4.68×10-05 | |
Cpgi5563 Cpgi5563tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
4.70×10-05 | |
Cpgi15344 Cpgi15344tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
4.70×10-05 | |
Tmc6 Tmc6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
4.80×10-05 | |
Rundc1 Rundc1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
4.81×10-05 | |
Fads1 Fads1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
4.81×10-05 | |
Col6a3 Col6a3em1(IMPC)Kmpc |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
KMPC IMPC |
4.81×10-05 | |
Ap4m1 Ap4m1tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
4.82×10-05 | |
Ano8 Ano8em1(IMPC)J |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
4.83×10-05 | |
Xbp1 Xbp1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
HMGU EuroPhenome |
4.85×10-05 | |
Parp4 Parp4em1(IMPC)Mbp |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
4.86×10-05 | |
Trpm1 Trpm1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.93×10-05 | |
Llgl2 Llgl2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
4.94×10-05 | |
Ntrk2 Ntrk2tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
4.98×10-05 | |
Brwd1 Brwd1em1(IMPC)Tcp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
5.01×10-05 | |
Rhpn1 Rhpn1tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
5.01×10-05 | |
Stt3b Stt3bem1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.06×10-05 | |
Esco1 Esco1tm1(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
5.06×10-05 | |
Kcnh3 Kcnh3tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.06×10-05 | |
Arhgap20 Arhgap20em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
5.07×10-05 | |
D630045J12Rik D630045J12Riktm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
5.07×10-05 | |
Yae1d1 Yae1d1tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
5.10×10-05 | |
Rab43 Rab43tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
5.11×10-05 | |
Rsbn1 Rsbn1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.13×10-05 | |
Pdgfrb Pdgfrbtm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
5.19×10-05 | |
Ints12 Ints12tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
5.20×10-05 | |
Ceacam16 Ceacam16tm1.1(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.22×10-05 | |
Grm3 Grm3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.22×10-05 | |
Sidt2 Sidt2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.22×10-05 | |
Rbl2 Rbl2tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.24×10-05 | |
Gatm Gatmtm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.25×10-05 | |
Usp12 Usp12tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
5.25×10-05 | |
Rhbdf2 Rhbdf2Rhbdf2 |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
5.31×10-05 | |
Tuft1 Tuft1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.35×10-05 | |
Dlg2 Dlg2tm1Dsb |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
5.36×10-05 | |
Nfkb1 Nfkb1tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
WTSI EuroPhenome |
5.38×10-05 | |
Irf8 Irf8tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
5.40×10-05 | |
Adcy2 Adcy2tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
5.41×10-05 | |
Emcn Emcnem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.45×10-05 | |
Urm1 Urm1em1(IMPC)J |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.46×10-05 | |
Eps8l2 Eps8l2tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.50×10-05 | |
Cap2 Cap2tm1e(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.51×10-05 | |
Fmnl2 Fmnl2em2(IMPC)Tcp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
5.58×10-05 | |
Cybrd1 Cybrd1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.61×10-05 | |
Celsr1 Celsr1Scy |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell EuroPhenome |
5.62×10-05 | |
Smyd2 Smyd2tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
WTSI EuroPhenome |
5.62×10-05 | |
Adipor1 Adipor1tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
5.63×10-05 | |
Aak1 Aak1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
5.63×10-05 | |
Psg20 Psg20em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.74×10-05 | |
E130308A19Rik E130308A19Rikem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
5.79×10-05 | |
Stx2 Stx2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.79×10-05 | |
Gm28050 Gm28050tm1.1(NCC)WCS |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
5.81×10-05 | |
Adss2 Adss2tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
5.85×10-05 | |
Usp24 Usp24tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
5.86×10-05 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HEM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
5.86×10-05 | |
Mettl22 Mettl22tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
5.86×10-05 | |
Gda Gdatm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.87×10-05 | |
Aco2 Aco2Gt(EUC0050e03)Hmgu |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.90×10-05 | |
Klc2 Klc2tm1e(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
5.91×10-05 | |
Ngfr Ngfrtm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
5.91×10-05 | |
Gfm1 Gfm1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
5.93×10-05 | |
Pknox1 Pknox1Gt(EUCJ0079d10)Hmgu |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
5.94×10-05 | |
Ube2o Ube2otm1.1(KOMP)Mbp |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
5.96×10-05 | |
Arhgef38 Arhgef38tm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
5.96×10-05 | |
Krt32 Krt32em1(IMPC)Kmpc |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
KMPC IMPC |
5.97×10-05 | |
Plcg2 Plcg2Ali14 |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
HMGU EuroPhenome |
5.97×10-05 | |
Chd6 Chd6em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
5.97×10-05 | |
Phrf1 Phrf1em1(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
5.97×10-05 | |
Npy5r Npy5rem1(IMPC)H |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.03×10-05 | |
Frrs1 Frrs1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
6.07×10-05 | |
Agl Agltm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.10×10-05 | |
Dbnl Dbnltm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
6.10×10-05 | |
Trmt10a Trmt10atm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
6.11×10-05 | |
Ehd1 Ehd1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
6.13×10-05 | |
Pycr1 Pycr1tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
6.13×10-05 | |
Ucp1 Ucp1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
HMGU IMPC |
6.13×10-05 | |
Mocos Mocosem2(IMPC)Ics |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
6.14×10-05 | |
Pgam5 Pgam5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
6.15×10-05 | |
Mettl22 Mettl22tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.18×10-05 | |
Irgm1 Irgm1em1(IMPC)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
6.20×10-05 | |
Gpcpd1 Gpcpd1em1(IMPC)Tcp |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
6.21×10-05 | |
Rab36 Rab36tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
6.27×10-05 | |
Tnfrsf1a Tnfrsf1aem1(IMPC)Ccpcz |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
6.37×10-05 | |
Ctsa Ctsatm2b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
6.39×10-05 | |
Ap2a2 Ap2a2em1(IMPC)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.40×10-05 | |
Padi4 Padi4em1(IMPC)Mbp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
6.41×10-05 | |
Il13 Il13tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
6.41×10-05 | |
Rfc1 Rfc1tm1b(KOMP)Mbp |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
6.46×10-05 | |
Col9a3 Col9a3em1(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
6.48×10-05 | |
Wdtc1 Wdtc1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.48×10-05 | |
Dscc1 Dscc1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
6.51×10-05 | |
Marchf9 Marchf9tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
6.52×10-05 | |
Tigit Tigittm1.1(IMPC)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
6.58×10-05 | |
Nudt16l1 Nudt16l1em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.62×10-05 | |
Crygs Crygstm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.63×10-05 | |
Aifm3 Aifm3em1(IMPC)Rbrc |
HOM | Late adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
RBRC IMPC |
6.64×10-05 | |
Suv39h2 Suv39h2em1(IMPC)Marc |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
6.65×10-05 | |
Ngdn Ngdntm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
6.72×10-05 | |
Rhag Rhagem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
6.75×10-05 | |
1700008P02Rik 1700008P02Rikem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.76×10-05 | |
Cdk15 Cdk15tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
6.77×10-05 | |
Wrap53 Wrap53tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.77×10-05 | |
Dusp16 Dusp16em1(IMPC)Tcp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
6.77×10-05 | |
Fndc7 Fndc7tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
6.79×10-05 | |
Krt34 Krt34em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
CCP-IMG IMPC |
6.82×10-05 | |
Zfp787 Zfp787em1(IMPC)J |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
6.82×10-05 | |
Slc10a3 Slc10a3em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
6.82×10-05 | |
Saysd1 Saysd1em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
6.83×10-05 | |
Spryd3 Spryd3tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
6.85×10-05 | |
Trappc10 Trappc10tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
6.85×10-05 | |
Anxa6 Anxa6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI MGP |
6.90×10-05 | |
Nucks1 Nucks1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
6.92×10-05 | |
Prdx6 Prdx6tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
6.94×10-05 | |
Ceacam23 Ceacam23em1(IMPC)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
6.99×10-05 | |
Ecrg4 Ecrg4tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
7.02×10-05 | |
C1qtnf1 C1qtnf1em1(IMPC)Mbp |
HOM | Late adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
7.02×10-05 | |
Notum Notumem1(IMPC)Tcp |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
7.03×10-05 | |
Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.03×10-05 | |
Nucks1 Nucks1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
HMGU IMPC |
7.07×10-05 | |
Rnf10 Rnf10tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
7.11×10-05 | |
Rcor2 Rcor2tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
WTSI MGP |
7.14×10-05 | |
Celf4 Celf4tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
7.15×10-05 | |
Cpgi15344 Cpgi15344tm1.1(NCC)WCS |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.16×10-05 | |
Cps1 Cps1em1(IMPC)H |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.17×10-05 | |
Dhx30 Dhx30tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
7.18×10-05 | |
Palm Palmem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.18×10-05 | |
Kctd19 Kctd19em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.19×10-05 | |
Fbxo11 Fbxo11Jf |
HET | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
MRC Harwell EuroPhenome |
7.24×10-05 | |
Tle4 Tle4em1(IMPC)Mbp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
UC Davis IMPC |
7.28×10-05 | |
Slc5a5 Slc5a5tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.29×10-05 | |
Tcf7l1 Tcf7l1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
7.30×10-05 | |
Fpr3 Fpr3tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
7.37×10-05 | |
Pgam5 Pgam5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
7.37×10-05 | |
Phf8 Phf8tm1dIcs |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
7.37×10-05 | |
Ppil3 Ppil3tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
7.38×10-05 | |
Palb2 Palb2tm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
7.40×10-05 | |
Aldh2 Aldh2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI EuroPhenome |
7.42×10-05 | |
Eftud2 Eftud2tm1b(KOMP)Wtsi |
HET | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
7.42×10-05 | |
Clock Clockem1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
7.44×10-05 | |
Mfsd1 Mfsd1em1(IMPC)Tcp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
7.47×10-05 | |
Rab33b Rab33bem1(IMPC)J |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
7.50×10-05 | |
Plscr3 Plscr3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
BCM IMPC |
7.51×10-05 | |
Tmem129 Tmem129tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
7.52×10-05 | |
Hells Hellstm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
7.52×10-05 | |
Zbtb24 Zbtb24tm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
7.55×10-05 | |
Mmp8 Mmp8tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Plasma Chemistry |
JAX IMPC |
7.58×10-05 | |
H1f10 H1f10tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
7.63×10-05 | |
Smyd4 Smyd4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
7.64×10-05 | |
Sag Sagtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.66×10-05 | |
Pacrg Pacrgem1(IMPC)J |
HOM | Late adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
7.67×10-05 | |
Aldh2 Aldh2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
7.67×10-05 | |
Fam186b Fam186btm1b(KOMP)Mbp |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
7.71×10-05 | |
Cxcl9 Cxcl9tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.72×10-05 | |
Elmod1 Elmod1tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating glycerol level | Glycerol Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
7.73×10-05 | |
Rnf169 Rnf169tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
MRC Harwell EuroPhenome |
7.73×10-05 | |
Dgkk Dgkkem1(IMPC)Ics |
HEM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
7.76×10-05 | |
Cfh Cfhtm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
7.77×10-05 | |
Serpinb10 Serpinb10em1(IMPC)Mbp |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
UC Davis IMPC |
7.83×10-05 | |
C2cd4b C2cd4bem1(IMPC)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
7.86×10-05 | |
Ypel4 Ypel4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
7.86×10-05 | |
Gpr146 Gpr146em1(IMPC)H |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
7.86×10-05 | |
Piezo2 Piezo2em2(IMPC)J |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
7.90×10-05 | |
Hgsnat Hgsnatem4(IMPC)Tcp |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
TCP IMPC |
7.99×10-05 | |
Snx15 Snx15tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.02×10-05 | |
Ulk3 Ulk3em2(IMPC)Tcp |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
8.03×10-05 | |
Glg1 Glg1tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
8.03×10-05 | |
Tcaim Tcaimtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.07×10-05 | |
Camsap3 Camsap3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
8.07×10-05 | |
Tti1 Tti1em1(IMPC)J |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.10×10-05 | |
Cbx6 Cbx6tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
8.11×10-05 | |
Stx2 Stx2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.11×10-05 | |
Ano4 Ano4em1(IMPC)Kmpc |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
KMPC IMPC |
8.14×10-05 | |
Angptl4 Angptl4tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.16×10-05 | |
Mier1 Mier1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating free fatty acids level | Free fatty acids Fasted Clinical Chemistry |
WTSI EuroPhenome |
8.25×10-05 | |
Acbd5 Acbd5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
8.26×10-05 | |
Rapgefl1 Rapgefl1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
8.29×10-05 | |
Glg1 Glg1tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
8.29×10-05 | |
Elk3 Elk3em1(IMPC)Ics |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
8.30×10-05 | |
Tnip1 Tnip1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.31×10-05 | |
Krt34 Krt34em1(IMPC)Ccpcz |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
CCP-IMG IMPC |
8.31×10-05 | |
Tbc1d22a Tbc1d22atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
8.32×10-05 | |
Stx8 Stx8tm2a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI MGP |
8.37×10-05 | |
Dctn4 Dctn4em1(IMPC)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
WTSI IMPC |
8.38×10-05 | |
Gfpt1 Gfpt1tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.38×10-05 | |
Zc3h12c Zc3h12cem1(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
8.38×10-05 | |
Dync1i2 Dync1i2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI MGP |
8.40×10-05 | |
Mocos Mocosem2(IMPC)Ics |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
8.41×10-05 | |
Serpinb2 Serpinb2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
8.43×10-05 | |
Colec10 Colec10em2(IMPC)Tcp |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
8.44×10-05 | |
Zfp182 Zfp182tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
8.44×10-05 | |
Rfc1 Rfc1tm1b(KOMP)Mbp |
HET | Early adult | decreased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
8.44×10-05 | |
Boc Boctm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MRC Harwell IMPC |
8.46×10-05 | |
Hbs1l Hbs1ltm1a(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
8.47×10-05 | |
Slc9a9 Slc9a9em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.47×10-05 | |
Nras Nrastm1b(EUCOMM)Hmgu |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.49×10-05 | |
Rnf144b Rnf144btm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
8.50×10-05 | |
Brd9 Brd9em1(IMPC)Tcp |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
8.51×10-05 | |
Rpia Rpiatm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI IMPC |
8.53×10-05 | |
Bcorl1 Bcorl1em1(IMPC)Tcp |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
TCP IMPC |
8.60×10-05 | |
Ttll4 Ttll4tm1a(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI EuroPhenome |
8.60×10-05 | |
C4bp C4bptm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
8.60×10-05 | |
Rexo2 Rexo2tm1b(EUCOMM)Wtsi |
HET | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
8.61×10-05 | |
Cav3 Cav3em1(IMPC)Kmpc |
HOM | Early adult | increased circulating LDL cholesterol level | LDL-cholesterol Clinical Chemistry |
KMPC IMPC |
8.66×10-05 | |
Gars1 Gars1em1(IMPC)Tcp |
HET | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
8.66×10-05 | |
Serpinb2 Serpinb2tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.66×10-05 | |
Pex3 Pex3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
8.67×10-05 | |
Acy3 Acy3em1(IMPC)J |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
JAX IMPC |
8.69×10-05 | |
Irgq Irgqem1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.71×10-05 | |
Hdac1 Hdac1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Fasted Clinical Chemistry |
HMGU EuroPhenome |
8.74×10-05 | |
Zfp532 Zfp532em1(IMPC)J |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
8.74×10-05 | |
Ap4e1 Ap4e1em1(IMPC)J |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
JAX IMPC |
8.76×10-05 | |
Grxcr1 Grxcr1em1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
8.82×10-05 | |
Slc38a2 Slc38a2tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
8.82×10-05 | |
Cstb Cstbtm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
8.89×10-05 | |
Rasal3 Rasal3tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
ICS IMPC |
8.97×10-05 | |
Fbxo41 Fbxo41tm1.1(KOMP)Vlcg |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
9.01×10-05 | |
Prr5 Prr5em1(IMPC)J |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
9.01×10-05 | |
Rab5c Rab5ctm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
9.02×10-05 | |
Fbxo9 Fbxo9tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
TCP IMPC |
9.03×10-05 | |
Dhrs7b Dhrs7bem1(IMPC)Mbp |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
9.03×10-05 | |
Dlec1 Dlec1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating triglyceride level | Triglycerides Fasted Clinical Chemistry |
HMGU EuroPhenome |
9.07×10-05 | |
Fto Ftotm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI EuroPhenome |
9.09×10-05 | |
Fa2h Fa2hem1(IMPC)Mbp |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
UC Davis IMPC |
9.09×10-05 | |
Setd1b Setd1btm1.2(IMPC)Wtsi |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
WTSI IMPC |
9.10×10-05 | |
Rec8 Rec8tm1b(KOMP)Wtsi |
HOM | Late adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.13×10-05 | |
Ehd1 Ehd1tm1a(EUCOMM)Wtsi |
HET | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
WTSI MGP |
9.20×10-05 | |
Nfasc Nfasctm1a(EUCOMM)Hmgu |
HET | Early adult | increased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
9.22×10-05 | |
Rab3gap2 Rab3gap2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
9.23×10-05 | |
Pabpc4 Pabpc4tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Clinical Chemistry |
WTSI IMPC |
9.24×10-05 | |
Zfp346 Zfp346tm1.1(KOMP)Vlcg |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
9.28×10-05 | |
Pon2 Pon2tm1b(EUCOMM)Hmgu |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.32×10-05 | |
Rad1 Rad1tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
JAX IMPC |
9.45×10-05 | |
Taf2 Taf2tm1b(EUCOMM)Hmgu |
HET | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
9.50×10-05 | |
Psph Psphtm1.1(KOMP)Vlcg |
HET | Early adult | decreased circulating triglyceride level | Triglycerides Clinical Chemistry |
TCP IMPC |
9.53×10-05 | |
Itga8 Itga8tm1b(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acids Clinical Chemistry |
JAX IMPC |
9.56×10-05 | |
Pdpr Pdprtm1b(EUCOMM)Wtsi |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
ICS IMPC |
9.59×10-05 | |
Snx15 Snx15tm1.1(KOMP)Vlcg |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.62×10-05 | |
Defb14 Defb14tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating glycerol level | Glycerol Clinical Chemistry |
WTSI IMPC |
9.63×10-05 | |
Efhb Efhbem1(IMPC)J |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
JAX IMPC |
9.64×10-05 | |
Rnase10 Rnase10tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating triglyceride level | Triglyceride Clinical Chemistry |
ICS EuroPhenome |
9.65×10-05 | |
Ints6l Ints6lem1(IMPC)Marc |
HEM | Early adult | increased circulating triglyceride level | Triglycerides Clinical Chemistry |
MARC IMPC |
9.65×10-05 | |
Nes Nestm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating cholesterol level | Total cholesterol Plasma Chemistry |
JAX IMPC |
9.72×10-05 | |
Pepd Pepdtm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
HMGU IMPC |
9.75×10-05 | |
Cd22 Cd22tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
UC Davis IMPC |
9.77×10-05 | |
Cog2 Cog2tm1a(KOMP)Wtsi |
HET | Early adult | increased circulating free fatty acids level | Free fatty acid Clinical Chemistry |
WTSI MGP |
9.85×10-05 | |
Slc9a4 Slc9a4tm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
MRC Harwell IMPC |
9.90×10-05 | |
Fam83h Fam83hem1(IMPC)Ccpcz |
HOM | Early adult | abnormal cholesterol homeostasis | Cholesterol ratio Clinical Chemistry |
CCP-IMG IMPC |
9.97×10-05 | |
Padi3 Padi3tm1b(KOMP)Wtsi |
HOM | Early adult | increased circulating HDL cholesterol level | HDL-cholesterol Clinical Chemistry |
ICS IMPC |
9.98×10-05 | |
Obp2a Obp2atm1b(EUCOMM)Wtsi |
HOM | Early adult | increased circulating cholesterol level | Total cholesterol Clinical Chemistry |
ICS IMPC |
9.99×10-05 |